Case Study: GC Biopharma achieves faster, more stable manufacturing operations with Nutanix Kubernetes Platform

A Nutanix Case Study

Preview of the GC Biopharma Case Study

GC Biopharma scales MES with Nutanix through 8 infrastructure expansions

GC Biopharma, a South Korean biotechnology company, faced challenges with its decentralized legacy IT infrastructure, which lacked interconnectivity and impacted the stability of its critical Manufacturing Execution System (MES). To modernize its operations and improve scalability, the company partnered with Nutanix to implement the Nutanix Kubernetes Platform (NKP).

Nutanix provided a container-based solution with NKP, enabling a microservices architecture for the MES. This resulted in improved database and I/O performance, non-disruptive upgrades for business continuity, and enhanced operational efficiency through centralized management. Since 2020, the platform has supported eight infrastructure expansions, allowing GC Biopharma to respond more quickly to production changes and strengthen its overall competitiveness.


View this case study…

Nutanix

841 Case Studies